Vertex Ventures HC

Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Vertex Ventures HC Information

Geographic Data

Vertex Ventures HC headquarters map

Address: 76 South Park Street

City: San Francisco

State: CA

Zip: 94107

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

7,514,980Website Global Rank

515Website Monthly Traffic

Twitter Followers

Description

Vertex Ventures HC invests in various sectors of the healthcare industry, including biopharmaceuticals, medical devices and digital health. Their portfolio includes companies at all stages of development, from early-stage companies testing transformative technologies to commercial-stage companies seeking additional growth. With a focus on areas with significant unmet need, Vertex seeks to build great companies that improve the health and quality of human life. They take an active role in our portfolio companies and work with exceptional entrepreneurs, industry partners and fellow venture investors to create value. Their global investment professionals bring deep scientific, medical and business knowledge to every investment they make.

Contact Phone:
+16507298810

Contact Email:

Announced Date Company Transaction Money Raised
9/2021 Obsidian Therapeutics Series B 0
4/2015 Twelve Series C 35M
6/2016 Earlens Series C 0
5/2015 Moximed Series B 33M
4/2021 Boundless Bio Series B 105M
5/2023 Boundless Bio Series C 0
6/2019 BlackThorn Therapeutics Series B 76M
12/2017 Obsidian Therapeutics Series A 0
4/2014 Nuvaira Series D 42M
7/2013 SENSIMED Series C 8.4M
9/2018 Twentyeight-Seven Therapeutics Series A 65M
7/2020 Elevation Oncology Series A 32.5M
9/2015 Kona Medical Debt Financing 10M
10/2017 Visterra Series C 0
12/2022 SonoThera Series A 0
3/2017 Moximed Series C 50M
9/2014 Ivantis Series B 25M
2/2019 Nuvaira Equity 79M
12/2019 Epirium Bio Series A 0
11/2020 Elevation Oncology Series B 65M
10/2022 Matchpoint Therapeutics Series A 70M
10/2018 Earlens Series D 0
7/2016 Innoventure Series A -
7/2021 NeuSpera Medical Series C 65M
9/2020 Palleon Pharmaceuticals Series B 100M
10/2017 Palleon Pharmaceuticals Series A 47.6M
6/2017 Bicycle Therapeutics Series B 52M
6/2017 Earlens Series C 0
9/2021 Allay Therapeutics Series C 60M
10/2014 Visterra Series B 30M
5/2019 Twentyeight-Seven Therapeutics Series A 15M
8/2021 Sonoma BioTherapeutics Series B 0
6/2016 Visterra Series C 23.1M
9/2021 Allay Therapeutics Series C 0
9/2021 Obsidian Therapeutics Series B 0
8/2021 Sonoma BioTherapeutics Series B 0
7/2021 NeuSpera Medical Series C 0
4/2021 Boundless Bio Series B 0
11/2020 Elevation Oncology Series B 0
9/2020 Palleon Pharmaceuticals Series B 0
7/2020 Elevation Oncology Series A 0
12/2019 Epirium Bio Series A 0
6/2019 BlackThorn Therapeutics Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research